Scientists are reporting an advance toward a fast, inexpensive urine test to detect and monitor the effectiveness of treatment for tuberculosis (TB), which is on a rampage in the developing world. Their study appears in the American Chemical Society (ACS)'s journal Analytical Chemistry.
A team led by Virander Singh Chauhan and Ranjan Kumar Nanda notes that TB strikes an estimated 10 million people and kills 3 million each year, mostly in developing countries. Health care workers diagnose the disease by identifying the TB bacterium in sputum or blood samples. But current tests tend to be time-consuming, sometimes taking days or weeks to give results. The tests also require the use of specially trained personnel or expensive equipment that might not be available in some areas.
The scientists describe an advance toward a test that overcomes these drawbacks. They analyzed so-called volatile organic compounds (VOCs) substances that evaporate easily in the air present in the urine of TB patients and compared them with VOCs in the urine of healthy patients. The scientists found that infection with TB produces a distinct pattern of certain VOCs in much the same way that distinct fingerprint patterns can identify individuals. Identification of these patterns sets the stage for developing a portable "electronic nose" that can quickly sniff urine samples to detect TB, the scientists suggest.
The authors acknowledged funding from the Government of Indias Department of Biotechnology and International Center for Genetic Engineering and Biotechnology, New Delhi.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.